Global medical technology and biomedicine have developed rapidly in recent years. Every year, new inventions, new breakthroughs and new research appear in front of people's eyes, bringing new hope to patients and seeking well-being for the overall health of mankind. At the end of 2013, we take this opportunity to take stock of new technologies and new medical achievements that may attract people's attention in 2014, including now hot wearable devices, and genes and immunotherapy that subvert traditional treatment. Among these new products, there are many Chinese investors who have already entered first. 1. Wearable devices and somatosensory devices A wearable device is a portable device that is worn directly on the body or integrated into the user's clothes or accessories. Wearable devices are not only a hardware device, but also realize powerful functions through software support, data interaction, and cloud interaction. According to a survey released by the Consumer Electronics Association this month, more than 13% of Americans are interested in buying wearable devices, which is more than three times the 3% in 2012. And people with such devices account for 9% of the US consumer group. Google Glass developed by Google may become a good helper for surgeons. Philips and Accenture recently developed a medical system to implant Google Glass on the operating table. Microsoft's somatosensory device has also been proven to be used in the operating room. The device can help surgeons rotate and magnify the images on the instrument, eliminating the need for keyboards and careless operation. The listed companies engaged in the wearable device business in China mainly include Beijing Junzheng (300223.SZ), Fenda Technology (002681.SZ) and Zhongying Electronics (300327.SZ). 2. Personalized medical center and telemedicine According to the Secretary of the US Department of Family and Community Health, family physicians and remote doctors will become the entry points for patient treatment interventions and will also be the foundation of personalized medical centers. The personalized medical center can provide the same day registration and remote diagnosis and treatment services, emphasize health and disease prevention, and provide a full range of services for patients by combining the resources of nurses, pharmacists and doctors. The US Department of Veterans Affairs has issued a report that in 2012, nearly 500,000 veterans in the United States received telemedicine services through 150 veterans clinics and 750 emergency rooms, including telemedicine inquiries and home monitoring. In remote diagnosis and treatment, cloud electronic health cases are also gradually sought after by physicians. Recently, the American Black Book Agency released the survey results, saying that more and more independent physicians have begun to use the cloud electronic health case system. One of the main reasons is that it is cheaper to buy such a system than a client / server system. In China, Xikang China Group, a subsidiary of Neusoft Group (600718.SH), provides remote, monitoring equipment, relying on well-known medical experts and professional health consultant teams from superior hospitals to provide individuals, families and people with multi-level, multi-dimensional and integrated health. Management services. It applies Internet, Internet of Things and cloud computing technologies to build a health management network covering individuals, families and communities, and forms a B2B, B2C e-commerce model. 3. IBM supercomputer Watson Watson is a super calculator newly developed by IBM, which has faster calculation and better memory. Now this system is increasingly being moved into the medical field. The Anderson Cancer Center in the United States is using this system to study eight cancer treatments. IBM and the Sloan Kettering Cancer Center are also collaborating to develop a tumor system to help doctors better provide personalized medical services for patients. In China, Tiantong (600330.SH) signed an agreement with the National Defense University this year. Both parties actively promote the work of a new generation of supercomputers, with Tiantong as the production base. The National University of Defense Technology is the undertaker of Tianhe No. 1 and No. 2 supercomputers. Tianhe No. 2 won the title of the world's fastest computer in June this year. Inspur Information (000977.SZ) is responsible for the research and development of part of the hardware of "Inspur Tiansuo high-end fault-tolerant computer". The specific content is: the development, design and testing of various subsystems and sub-module boards, including principle design, layout, integrated debugging, power System design, development and testing, chassis design, development and testing. High-end fault-tolerant computers are mainly used in finance, telecommunications, energy, government and other important areas related to national economy and people's livelihood and national strategic security. 4. Immunotherapy and gene therapy As we all know, traditional chemotherapy for cancer will kill cancer cells and normal cells at the same time, which has quite serious side effects. Immune system therapy is able to handle these side effects very well. In recent years, immunotherapy has developed rapidly. The University of California, San Francisco has found that this treatment can be used for metastatic melanoma and lung cancer, which have low cure rates in common cancer therapies. For many years, researchers have wanted to use gene therapy to treat diseases caused by genetic mutations in the human body. Shinya Yamanaka, a famous Japanese stem cell research scientist and a professor at Kyoto University in Japan, invented induced pluripotent stem cells in 2006 to help people better understand this treatment. Researchers can use the patient's epidermal cells to cultivate induced pluripotent stem cells. The stem cells will be implanted into the human body to repair and treat diseases after the cultivation is completed. Domestic companies engaged in the production of immunotherapy drugs include Haixin (600851.SH). The company's new drug "antigen-sensitized human dendritic cells (APDC)" can be used to treat rectal cancer. Haixin Biotechnology Co., Ltd. 51%) in cooperation with Shanghai Second Military Medical University. The drug works by using antigen-sensitized dendritic cells to stimulate tumor-specific immunity, thereby killing tumor cells. The pre-clinical research on blood and bone marrow hematopoietic system cancer and cancer patient immune recovery anticancer drugs jointly developed by Qianjiang Pharmaceuticals, a subsidiary of Zhongzhu Holdings (600568.SH), and TNI Biotechnology in the United States is undergoing verification, and the US Food and Drug Administration The FDA (FDA) agreed to enter the Phase III clinical trial in August this year. Among the domestic A-share listed companies, Zhongyuan Xiehe (600645.SH) is mainly engaged in the development of life science and technology, industrialization of stem cell genetic engineering, biomedicine and gene pharmacy.
Wooden Stamps are generally used as stationery on documents to identify or sign, while children`s stationery stamps generally use letters, simple geometric figures, or cartoon characters. The use of common wooden stamps is first stained with paint and then printed. Wooden stamps are generally made of wood.
The customer has a personalized pattern stamp or stamp shape production requirements, we can provide customers with customized services.
Wooden Stamps Wooden Stamps,Gift Wooden Stamp,Wooden Square Stamp,Mini Wooden Stamp Triple C International (Shenzhen) Co.,Ltd. , https://www.ccc-triple.com
4 major trends in global pharmaceutical biotechnology in 2014